个人内表观遗传异质性是晚期前列腺癌的表型亚型的基础
Kei Mizuno1, Sheng-Yu Ku1, Varadha Balaji Venkadakrishnan1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Nature communications
|July 2, 2025
概括
这项研究揭示了表观遗传变化如何驱动抵抗割的前列腺癌 (CRPC) 和神经内分泌前列腺癌 (NEPC) 的异质性. 整合DNA甲基化,RNA测序和基因素标记,确定了晚期前列腺癌中转录重编程的机制.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 抗割前列腺癌 (CRPC) 是一种异质性疾病,具有多种表型.
- 瘤可以保留光线标记物或失去荷尔蒙依赖,获得神经内分泌特征 (NEPC).
- 对于个体患者中瘤转移的重叠和多样性的理解有限.
研究的目的:
- 在CRPC/NEPC患者的转移性病变中表征表观遗传异质.
- 在晚期前列腺癌中确定驱动转录重编程的机制.
- 整合多个OMC数据,以全面了解CRPC/NEPC多样性.
主要方法:
- 组合的DNA甲基化,RNA测序,H3K27ac和H3K27me3分析.
- 对CRPC/NEPC患者转移性病变的分析.
- 整合性分析将DNA甲基化与基因表达和基因素修饰联系起来.
主要成果:
- 根据基因组位置 (H3K27ac,H3K27me3,促进体,基因体) 确定了DNA甲基化驱动的基因链接.
- 揭示了导致瘤谱系关键基因失调的机制 (ASCL1,AR) 和治疗点 (PSMA,DLL3,STEAP1,B7-H3).
- 在CRPC/NEPC中突出显示了个体内表观遗传异质性.
结论:
- 结合DNA甲基化,RNA测序和基因素标记,可以深入了解表观遗传异质性.
- 确定了驱动转录性重编程的假定机制,用于割抵抗性前列腺癌.
- 这种多组的方法可以为了解CRPC/NEPC多样性和治疗点的识别提供信息.
更多相关视频
10:38Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
9.1K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Inheritance of Chromatin Structures
6.6K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.6K
Epistasis Analysis
5.2K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.2K
Epistasis
47.8K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
47.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
